S

SyntekaBio Inc
KOSDAQ:226330

Watchlist Manager
SyntekaBio Inc
KOSDAQ:226330
Watchlist
Price: 1 497 KRW -4.71% Market Closed
Market Cap: ₩36.3B

Wall St Price Targets

Price Targets Summary
SyntekaBio Inc

There are no price targets for SyntekaBio Inc.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
SyntekaBio Inc Competitors:
Price Targets
CORE
Allcore SpA
112% Upside
8987
Japan Excellent Inc
15% Upside
TFM
Thai Union Feedmill PCL
20% Upside

Revenue
Forecast

43% / Year
Past Growth
340% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
43% / Year
Past Growth
340% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 7 years, the compound annual growth rate for Revenue has been 43%. The projected CAGR for the next 1 year is 340%.

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for SyntekaBio Inc

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for SyntekaBio Inc

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Net Income Forecast
is not available for SyntekaBio Inc
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is SyntekaBio Inc's stock price target?
Not Available

SyntekaBio Inc does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for SyntekaBio Inc?
Projected CAGR
340%

Over the last 7 years, the compound annual growth rate for Revenue has been 43%. The projected CAGR for the next 1 year is 340%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett